Shares of Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX - Get Free Report) person been assigned an mean proposal of "Moderate Buy" from nan 5 investigation firms that are presently covering nan stock, Marketbeat.com reports. One finance expert has rated nan banal pinch a hold…
This communicative appeared connected marketbeat.com, 2024-10-26 10:51:43.